 xxxd289xxx  (wyeth).   xxxd289xxx  is a tissue-specific selective  xxxg730xxx  modulator being developed by wyeth pharmaceuticals (formerly wyeth-ayerst laboratories) to be used alone for the prevention and treatment of osteoporosis in postmenopausal women and in combination with premarin for menopausal symptoms. as of march and june 2004, worldwide phase iii trials for  xxxd289xxx , and  xxxd289xxx  in combination with premarin, were ongoing.